Skip to main content
Erschienen in: Current Treatment Options in Neurology 8/2014

01.08.2014 | Neuro-oncology (R Soffietti, Section Editor)

Role of Stereotactic Radiosurgery in Meningiomas and Vestibular Schwannomas

verfasst von: Jeffrey T. Jacob, MD, Michael J. Link, MD, Bruce E. Pollock, MD

Erschienen in: Current Treatment Options in Neurology | Ausgabe 8/2014

Einloggen, um Zugang zu erhalten

Opinion statement

Intracranial meningiomas and vestibular schwannomas (VS, aka acoustic neuromas) are typically benign, slow-growing, non-invasive neoplasms. The imaging and radiobiologic characteristics of these tumors make them good candidates for stereotactic radiosurgery (SRS), a technique that has been in use for over three decades. Patient selection is critical for successful SRS: small- to moderate-sized tumors can be effectively treated with SRS if the patient does not have symptoms related to mass effect. Factors related to tumor control in meningioma SRS include histology, history of prior surgery, and volume. Tumor control rates after SRS is significantly lower for patients with WHO grade II or III meningiomas compared to patients with WHO grade I meningiomas. The risk of radiation-related complications is higher for patients with larger tumors and tumors located over the convexities or along the falx. Patients with small-volume non-operated skull base or tentorial WHO grade I meningiomas typically have the best outcomes after SRS. Radiosurgery of sporadic VS provides a high tumor control rate (92–95 %), with less than a 5 % risk of facial weakness. Hearing preservation progressively declines for 10 years or more after SRS, and the primary factors related to long-term preservation of useful hearing are tumor size and pre-SRS hearing class. Radiosurgery remains an important option for patients with neurofibromatosis type 2, but tumor control is lower and the risk of cranial nerve deficits is greater when compared to patients with sporadic VS.
Literatur
1.
Zurück zum Zitat Cushing H, Eisenhardt L. In: Meningiomas: Their classification, regional behavior, life history, and surgical end results. Springfield: Charles C. Thomas; 1938. Cushing H, Eisenhardt L. In: Meningiomas: Their classification, regional behavior, life history, and surgical end results. Springfield: Charles C. Thomas; 1938.
3.
Zurück zum Zitat Couldwell WT, Kan P, Liu JK, et al. Decompression of cavernous sinus meningioma for preservation and improvement of cranial nerve function. Technical Note J Neurosurg. 2006;105:148–52.CrossRef Couldwell WT, Kan P, Liu JK, et al. Decompression of cavernous sinus meningioma for preservation and improvement of cranial nerve function. Technical Note J Neurosurg. 2006;105:148–52.CrossRef
4.
Zurück zum Zitat Di Maio S, Ramanathan D, Garcia-Lopez R, et al. Evolution and future of skull base surgery: the paradigm of skull base meningiomas. World Neurosurg. 2012;78:260–75.PubMedCrossRef Di Maio S, Ramanathan D, Garcia-Lopez R, et al. Evolution and future of skull base surgery: the paradigm of skull base meningiomas. World Neurosurg. 2012;78:260–75.PubMedCrossRef
5.
Zurück zum Zitat Dufour H, Muracciole X, Métellus P, et al. Long-term tumor control and functional outcome in patients with cavernous sinus meningiomas treated by radiotherapy with or without previous surgery: is there an alternative to aggressive tumor removal? Neurosurgery. 2001;48:285–96.PubMed Dufour H, Muracciole X, Métellus P, et al. Long-term tumor control and functional outcome in patients with cavernous sinus meningiomas treated by radiotherapy with or without previous surgery: is there an alternative to aggressive tumor removal? Neurosurgery. 2001;48:285–96.PubMed
6.
Zurück zum Zitat Klink DF, Sampath P, Miller NR, et al. Long-term visual outcome after nonradical microsurgery in patients with parasellar and cavernous sinus meningiomas. Neurosurgery. 2000;47:24–32.PubMed Klink DF, Sampath P, Miller NR, et al. Long-term visual outcome after nonradical microsurgery in patients with parasellar and cavernous sinus meningiomas. Neurosurgery. 2000;47:24–32.PubMed
7.
Zurück zum Zitat Mathiesen T, Lindquist C, Kihlström L, et al. Recurrence of cranial base meningiomas. Neurosurgery. 1996;39:2–9.PubMedCrossRef Mathiesen T, Lindquist C, Kihlström L, et al. Recurrence of cranial base meningiomas. Neurosurgery. 1996;39:2–9.PubMedCrossRef
8.
Zurück zum Zitat Stafford SL, Perry A, Suman VJ, et al. Primarily resected meningiomas: outcome and prognostic factors in 581 Mayo Clinic patients, 1978 through 1988. Mayo Clin Proc. 1998;73:936–42.PubMedCrossRef Stafford SL, Perry A, Suman VJ, et al. Primarily resected meningiomas: outcome and prognostic factors in 581 Mayo Clinic patients, 1978 through 1988. Mayo Clin Proc. 1998;73:936–42.PubMedCrossRef
9.
Zurück zum Zitat Sughrue ME, Kane AJ, Shangari G, et al. The relevance of Simpson grade I and II resection in modern neurosurgical treatment of World Health Organization grade I meningiomas. J Neurosurg. 2010;113:1029–35.PubMedCrossRef Sughrue ME, Kane AJ, Shangari G, et al. The relevance of Simpson grade I and II resection in modern neurosurgical treatment of World Health Organization grade I meningiomas. J Neurosurg. 2010;113:1029–35.PubMedCrossRef
10.
Zurück zum Zitat Goldsmith BJ, Wara WM, Wilson CB, et al. Postoperative irradiation for subtotally resected meningiomas. A retrospective analysis of 140 patients treated from 1967 to 1990. J Neurosurg. 1994;80:195–201.PubMedCrossRef Goldsmith BJ, Wara WM, Wilson CB, et al. Postoperative irradiation for subtotally resected meningiomas. A retrospective analysis of 140 patients treated from 1967 to 1990. J Neurosurg. 1994;80:195–201.PubMedCrossRef
11.
Zurück zum Zitat Métellus P, Batra S, Karkar S, et al. Fractionated conformal radiotherapy in the management of cavernous sinus meningiomas: long-term functional outcome and tumor control at a single institution. Int J Radiat Oncol Biol Phys. 2010;78:836–43.PubMedCrossRef Métellus P, Batra S, Karkar S, et al. Fractionated conformal radiotherapy in the management of cavernous sinus meningiomas: long-term functional outcome and tumor control at a single institution. Int J Radiat Oncol Biol Phys. 2010;78:836–43.PubMedCrossRef
12.
Zurück zum Zitat Pasquier D, Bijmolt S, Veninga T, et al. Atypical and malignant meningioma: outcome and prognostic factors in 119 irradiated patients. A multicenter, retrospective study of the Rare Cancer Network. Int J Radiat Oncol Biol Phys. 2008;71:1388–93.PubMedCrossRef Pasquier D, Bijmolt S, Veninga T, et al. Atypical and malignant meningioma: outcome and prognostic factors in 119 irradiated patients. A multicenter, retrospective study of the Rare Cancer Network. Int J Radiat Oncol Biol Phys. 2008;71:1388–93.PubMedCrossRef
13.
Zurück zum Zitat Rosenberg LA, Prayson RA, Lee J, et al. Long-term experience with world health organization grade III (malignant) meningiomas at a single institution. Int J Radiat Oncol Biol Phys. 2009;74:427–32.PubMedCrossRef Rosenberg LA, Prayson RA, Lee J, et al. Long-term experience with world health organization grade III (malignant) meningiomas at a single institution. Int J Radiat Oncol Biol Phys. 2009;74:427–32.PubMedCrossRef
14.
Zurück zum Zitat Slater JD, Loredo LN, Chung A, et al. Fractionated proton radiotherapy for benign cavernous sinus meningiomas. Int J Radiat Oncol Biol Phys. 2012;83:e633–7.PubMedCrossRef Slater JD, Loredo LN, Chung A, et al. Fractionated proton radiotherapy for benign cavernous sinus meningiomas. Int J Radiat Oncol Biol Phys. 2012;83:e633–7.PubMedCrossRef
15.
Zurück zum Zitat Colombo F, Casentini C, Cavedon C, et al. Cyberknife radiosurgery for benign meningiomas: short-term results in 199 patients. Neurosurgery. 2009;64:A7–13.PubMedCrossRef Colombo F, Casentini C, Cavedon C, et al. Cyberknife radiosurgery for benign meningiomas: short-term results in 199 patients. Neurosurgery. 2009;64:A7–13.PubMedCrossRef
16.
Zurück zum Zitat Kollová A, Liscák R, Novotný Jr J, et al. Gamma knife surgery for benign meningioma. J Neurosurg. 2007;2007:325–36.CrossRef Kollová A, Liscák R, Novotný Jr J, et al. Gamma knife surgery for benign meningioma. J Neurosurg. 2007;2007:325–36.CrossRef
17.
Zurück zum Zitat Kondziolka D, Mathieu D, Lunsford LD, et al. Radiosurgery as definitive management of intracranial meningiomas. Neurosurgery. 2008;62:53–60.PubMedCrossRef Kondziolka D, Mathieu D, Lunsford LD, et al. Radiosurgery as definitive management of intracranial meningiomas. Neurosurgery. 2008;62:53–60.PubMedCrossRef
18.
Zurück zum Zitat Pollock BE, Stafford SL, Link MJ, et al. Single-fraction radiosurgery of benign intracranial meningiomas. Neurosurgery. 2012;71:604–13.PubMedCrossRef Pollock BE, Stafford SL, Link MJ, et al. Single-fraction radiosurgery of benign intracranial meningiomas. Neurosurgery. 2012;71:604–13.PubMedCrossRef
19.••
Zurück zum Zitat Santacroce A, Waller M, Régis J, et al. Long-term tumor control of benign intracranial meningiomas after radiosurgery in a series of 4565 patients. Neurosurgery. 2012;70:32–9. The largest series (n = 4565) on single-fraction SRS of benign (WHO grade I) intracranial meningiomas. All the patients had at least five years of follow-up after SRS. Tumor control was higher for imaging-defined tumors vs. operated grade I tumors, for female vs. male patients, for sporadic vs. multiple meningiomas, and for skull base vs. convexity tumors.PubMedCrossRef Santacroce A, Waller M, Régis J, et al. Long-term tumor control of benign intracranial meningiomas after radiosurgery in a series of 4565 patients. Neurosurgery. 2012;70:32–9. The largest series (n = 4565) on single-fraction SRS of benign (WHO grade I) intracranial meningiomas. All the patients had at least five years of follow-up after SRS. Tumor control was higher for imaging-defined tumors vs. operated grade I tumors, for female vs. male patients, for sporadic vs. multiple meningiomas, and for skull base vs. convexity tumors.PubMedCrossRef
20.•
Zurück zum Zitat Pollock BE, Stafford SL, Link MJ, et al. Stereotactic radiosurgery of WHO grade II and III intracranial meningiomas: treatment results based on a 22-year experience. Cancer. 2012;118:1048–54. This study documents that tumor control is much worse after SRS of WHO grade II–III meningiomas compared to WHO grade I meningiomas. Tumor progression despite prior EBRT and larger tumor volume were negative predictors of tumor control and survival after SRS.PubMedCrossRef Pollock BE, Stafford SL, Link MJ, et al. Stereotactic radiosurgery of WHO grade II and III intracranial meningiomas: treatment results based on a 22-year experience. Cancer. 2012;118:1048–54. This study documents that tumor control is much worse after SRS of WHO grade II–III meningiomas compared to WHO grade I meningiomas. Tumor progression despite prior EBRT and larger tumor volume were negative predictors of tumor control and survival after SRS.PubMedCrossRef
21.
Zurück zum Zitat Chopra R, Kondziolka D, Niranjan A, et al. Long-term follow-up of acoustic schwannoma radiosurgery with marginal tumor doses of 12 to 13 Gy. Int J Radiat Oncol Biol Phys. 2007;68:845–51.PubMedCrossRef Chopra R, Kondziolka D, Niranjan A, et al. Long-term follow-up of acoustic schwannoma radiosurgery with marginal tumor doses of 12 to 13 Gy. Int J Radiat Oncol Biol Phys. 2007;68:845–51.PubMedCrossRef
22.
Zurück zum Zitat Link MJ, Driscoll CL, Foote RL, et al. Radiation therapy and radiosurgery for vestibular schwannomas: indications, techniques, and results. Otolaryngol Clin North Am. 2012;45(2):353–66.PubMedCrossRef Link MJ, Driscoll CL, Foote RL, et al. Radiation therapy and radiosurgery for vestibular schwannomas: indications, techniques, and results. Otolaryngol Clin North Am. 2012;45(2):353–66.PubMedCrossRef
23.
Zurück zum Zitat Friedman WA, Bradshaw P, Myers A, et al. Linear accelerator radiosurgery for vestibular schwannomas. J Neurosurg. 2006;105:657–61.PubMedCrossRef Friedman WA, Bradshaw P, Myers A, et al. Linear accelerator radiosurgery for vestibular schwannomas. J Neurosurg. 2006;105:657–61.PubMedCrossRef
24.
Zurück zum Zitat Chang SD, Gibbs I, Sakamoto G, et al. Staged stereotactic irradiation for acoustic neuromas. Neurosurgery. 2005;56:1254–63.PubMedCrossRef Chang SD, Gibbs I, Sakamoto G, et al. Staged stereotactic irradiation for acoustic neuromas. Neurosurgery. 2005;56:1254–63.PubMedCrossRef
25.
Zurück zum Zitat Lederman G, Lowry J, Werthiem S, et al. Acoustic neuroma: potential benefits of fractionated stereotactic radiosurgery. Stereotact Funct Neurosurg. 1997;69:175–82.PubMedCrossRef Lederman G, Lowry J, Werthiem S, et al. Acoustic neuroma: potential benefits of fractionated stereotactic radiosurgery. Stereotact Funct Neurosurg. 1997;69:175–82.PubMedCrossRef
26.
Zurück zum Zitat Pollock BE. Management of vestibular schwannomas that enlarge after stereotactic radiosurgery: treatment recommendations based on a 15 year experience. Neurosurgery. 2006;58:241–8.PubMedCrossRef Pollock BE. Management of vestibular schwannomas that enlarge after stereotactic radiosurgery: treatment recommendations based on a 15 year experience. Neurosurgery. 2006;58:241–8.PubMedCrossRef
27.
Zurück zum Zitat Yang I, Sughrue ME, Han S, et al. Facial nerve preservation after vestibular schwannoma gamma knife radiosurgery. J Neurooncol. 2009;93:41–8.PubMedCrossRef Yang I, Sughrue ME, Han S, et al. Facial nerve preservation after vestibular schwannoma gamma knife radiosurgery. J Neurooncol. 2009;93:41–8.PubMedCrossRef
28.
Zurück zum Zitat Yang I, Sughrue ME, Han S, et al. A comprehensive analysis of hearing preservation after radiosurgery for vestibular schwannoma. J Neurosurg. 2010;112:851–9.PubMedCrossRef Yang I, Sughrue ME, Han S, et al. A comprehensive analysis of hearing preservation after radiosurgery for vestibular schwannoma. J Neurosurg. 2010;112:851–9.PubMedCrossRef
29.••
Zurück zum Zitat Carlson ML, Jacob JT, Pollock BE, et al. Long-term hearing outcomes following low-dose stereotactic radiosurgery for vestibular schwannoma: patterns of hearing loss and variables influencing audiometric decline. J Neurosurg. 2013;118:579–87. Study of patients undergoing low-dose (12-13 Gy) VS SRS with long-term longitudinal follow-up (median 9.3 years) and independent assessment of post-SRS hearing. By five years, less than 50 % of patients retained serviceable hearing. Factors related to hearing preservation included pre-SRS pure-tone average and tumor size.PubMedCrossRef Carlson ML, Jacob JT, Pollock BE, et al. Long-term hearing outcomes following low-dose stereotactic radiosurgery for vestibular schwannoma: patterns of hearing loss and variables influencing audiometric decline. J Neurosurg. 2013;118:579–87. Study of patients undergoing low-dose (12-13 Gy) VS SRS with long-term longitudinal follow-up (median 9.3 years) and independent assessment of post-SRS hearing. By five years, less than 50 % of patients retained serviceable hearing. Factors related to hearing preservation included pre-SRS pure-tone average and tumor size.PubMedCrossRef
30.
Zurück zum Zitat Jacob JT, Carlson ML, Schiefer TK, et al. Significance of cochlear dose in the radiosurgical treatment of vestibular schwannoma: controversies and unanswered questions. Neurosurgery. 2014;74:466–74.PubMedCrossRef Jacob JT, Carlson ML, Schiefer TK, et al. Significance of cochlear dose in the radiosurgical treatment of vestibular schwannoma: controversies and unanswered questions. Neurosurgery. 2014;74:466–74.PubMedCrossRef
31.
Zurück zum Zitat Pollock BE, Driscoll CL, Foote RL, et al. Patient outcomes after vestibular schwannoma management: a prospective comparison of microsurgical resection and stereotactic radiosurgery. Neurosurgery. 2006;59:77–85.PubMedCrossRef Pollock BE, Driscoll CL, Foote RL, et al. Patient outcomes after vestibular schwannoma management: a prospective comparison of microsurgical resection and stereotactic radiosurgery. Neurosurgery. 2006;59:77–85.PubMedCrossRef
32.
Zurück zum Zitat Mandl ES, Meijer OW, Slotman BJ, et al. Stereotactic radiation therapy for large vestibular schwannomas. Radiother Oncol. 2010;95:94–8.PubMedCrossRef Mandl ES, Meijer OW, Slotman BJ, et al. Stereotactic radiation therapy for large vestibular schwannomas. Radiother Oncol. 2010;95:94–8.PubMedCrossRef
33.
Zurück zum Zitat Pollock BE, Link MK. Vestibular schwannoma radiosurgery after previous surgical resection or stereotactic radiosurgery. Prog Neurol Surg. 2008;21:163–8.PubMedCrossRef Pollock BE, Link MK. Vestibular schwannoma radiosurgery after previous surgical resection or stereotactic radiosurgery. Prog Neurol Surg. 2008;21:163–8.PubMedCrossRef
34.
Zurück zum Zitat Pollock BE, Lunsford LD, Kondziolka D, et al. Vestibular schwannoma management. Part II. Failed radiosurgery and the role of delayed microsurgery. J Neurosurg. 1998;89:949–55.PubMedCrossRef Pollock BE, Lunsford LD, Kondziolka D, et al. Vestibular schwannoma management. Part II. Failed radiosurgery and the role of delayed microsurgery. J Neurosurg. 1998;89:949–55.PubMedCrossRef
35.
Zurück zum Zitat Roche PH, Khalil M, Thomassin JM, et al. Surgical removal of vestibular schwannoma after failed gamma knife radiosurgery. Prog Neurol Surg. 2008;21:152–7.PubMedCrossRef Roche PH, Khalil M, Thomassin JM, et al. Surgical removal of vestibular schwannoma after failed gamma knife radiosurgery. Prog Neurol Surg. 2008;21:152–7.PubMedCrossRef
36.
Zurück zum Zitat Dewan S, Norén G. Retreatment of vestibular schwannomas with gamma knife surgery. J Neurosurg. 2008;109(Suppl):144–8.PubMed Dewan S, Norén G. Retreatment of vestibular schwannomas with gamma knife surgery. J Neurosurg. 2008;109(Suppl):144–8.PubMed
37.
Zurück zum Zitat Yomo S, Arkha Y, Delsanti C, et al. Repeat gamma knife surgery for regrowth of vestibular schwannomas. Neurosurgery. 2009;64:45–52.CrossRef Yomo S, Arkha Y, Delsanti C, et al. Repeat gamma knife surgery for regrowth of vestibular schwannomas. Neurosurgery. 2009;64:45–52.CrossRef
38.
Zurück zum Zitat Mallory GW, Pollock BE, Foote RL, et al. Stereotactic radiosurgery for neurofibromatosis 2-associated vestibular schwannomas: toward dose optimization for tumor control and functional outcomes. Neurosurgery. 2014;74:292–300.PubMedCrossRef Mallory GW, Pollock BE, Foote RL, et al. Stereotactic radiosurgery for neurofibromatosis 2-associated vestibular schwannomas: toward dose optimization for tumor control and functional outcomes. Neurosurgery. 2014;74:292–300.PubMedCrossRef
39.
Zurück zum Zitat Carlson ML, Breen JT, Driscoll CL, et al. Cochlear implantation in patients with neurofibromatosis type 2: variables affecting auditory performance. Otol Neurotol. 2012;33:853–62.PubMedCrossRef Carlson ML, Breen JT, Driscoll CL, et al. Cochlear implantation in patients with neurofibromatosis type 2: variables affecting auditory performance. Otol Neurotol. 2012;33:853–62.PubMedCrossRef
40.•
Zurück zum Zitat Leavitt JA, Stafford SL, Link MJ, Pollock BE. Long-term evaluation of radiation-induced optic neuropathy after single-fraction stereotactic radiosurgery. Int J Radiat Oncol Biol Phys. 2013;87:524–7. This study shows that the risk of a radiation-induced optic neuropathy after single-fraction SRS is very low (approximately 1 %) if the maximum point dose to the optic nerves or chiasm is ≤ 12 Gy.PubMedCrossRef Leavitt JA, Stafford SL, Link MJ, Pollock BE. Long-term evaluation of radiation-induced optic neuropathy after single-fraction stereotactic radiosurgery. Int J Radiat Oncol Biol Phys. 2013;87:524–7. This study shows that the risk of a radiation-induced optic neuropathy after single-fraction SRS is very low (approximately 1 %) if the maximum point dose to the optic nerves or chiasm is ≤ 12 Gy.PubMedCrossRef
41.
Zurück zum Zitat Leenstra JL, Tanaka S, Kline RW, et al. Factors associated with endocrine deficits after stereotactic radiosurgery of pituitary adenomas. Neurosurgery. 2010;67:27–33.PubMedCrossRef Leenstra JL, Tanaka S, Kline RW, et al. Factors associated with endocrine deficits after stereotactic radiosurgery of pituitary adenomas. Neurosurgery. 2010;67:27–33.PubMedCrossRef
42.
Zurück zum Zitat Rowe J, Grainger A, Walton L, et al. Risk of malignancy after gamma knife stereotactic radiosurgery. Neurosurgery. 2007;60:60–6.PubMed Rowe J, Grainger A, Walton L, et al. Risk of malignancy after gamma knife stereotactic radiosurgery. Neurosurgery. 2007;60:60–6.PubMed
43.
Zurück zum Zitat Pollock BE, Lunsford LD, Kondziolka D, et al. Outcome analysis of acoustic neuroma management: a comparison of microsurgery and stereotactic radiosurgery. Neurosurgery. 1995;36:215–29.PubMedCrossRef Pollock BE, Lunsford LD, Kondziolka D, et al. Outcome analysis of acoustic neuroma management: a comparison of microsurgery and stereotactic radiosurgery. Neurosurgery. 1995;36:215–29.PubMedCrossRef
44.
Zurück zum Zitat Banerjee R, Moriarty J, Foote RL, Pollock BE. Comparison of the surgical and follow-up costs associated with microsurgical resection and stereotactic radiosurgery for vestibular schwannoma. J Neurosurg. 2008;108:1220–4.PubMedCrossRef Banerjee R, Moriarty J, Foote RL, Pollock BE. Comparison of the surgical and follow-up costs associated with microsurgical resection and stereotactic radiosurgery for vestibular schwannoma. J Neurosurg. 2008;108:1220–4.PubMedCrossRef
45.
Zurück zum Zitat Oya S, Kim S, Sade B, et al. The natural history of intracranial meningiomas. J Neurosurg. 2011;114:1250–6.PubMed Oya S, Kim S, Sade B, et al. The natural history of intracranial meningiomas. J Neurosurg. 2011;114:1250–6.PubMed
46.
Zurück zum Zitat Hashimoto N, Rabo CS, Okita Y, et al. Slower growth of skull base meningiomas compared with non-skull base meningiomas based on volumetric and biologic studies. J Neurosurg. 2012;116:574–80.PubMedCrossRef Hashimoto N, Rabo CS, Okita Y, et al. Slower growth of skull base meningiomas compared with non-skull base meningiomas based on volumetric and biologic studies. J Neurosurg. 2012;116:574–80.PubMedCrossRef
47.
Zurück zum Zitat Stangerup SE, Cayé-Thomasen P, Tos M. The natural history of vestibular schwannoma. Otol Neurotol. 2006;27:547–52.PubMedCrossRef Stangerup SE, Cayé-Thomasen P, Tos M. The natural history of vestibular schwannoma. Otol Neurotol. 2006;27:547–52.PubMedCrossRef
48.•
Zurück zum Zitat Stangerup SE, Thomsen J, Tos M, et al. Long-term hearing preservation in vestibular schwannoma. Otol Neurotol. 2010;31:271–5. Large longitudinal study (n = 932) of VS patients undergoing observation. Fifty-nine percent of patients with good hearing (speech discrimination score of >70 %) retained good hearing at mean follow-up of 4.7 years. In patients with 100 % speech discrimination at diagnosis, 69 % had good hearing at 10 or more years of observation.PubMedCrossRef Stangerup SE, Thomsen J, Tos M, et al. Long-term hearing preservation in vestibular schwannoma. Otol Neurotol. 2010;31:271–5. Large longitudinal study (n = 932) of VS patients undergoing observation. Fifty-nine percent of patients with good hearing (speech discrimination score of >70 %) retained good hearing at mean follow-up of 4.7 years. In patients with 100 % speech discrimination at diagnosis, 69 % had good hearing at 10 or more years of observation.PubMedCrossRef
Metadaten
Titel
Role of Stereotactic Radiosurgery in Meningiomas and Vestibular Schwannomas
verfasst von
Jeffrey T. Jacob, MD
Michael J. Link, MD
Bruce E. Pollock, MD
Publikationsdatum
01.08.2014
Verlag
Springer US
Erschienen in
Current Treatment Options in Neurology / Ausgabe 8/2014
Print ISSN: 1092-8480
Elektronische ISSN: 1534-3138
DOI
https://doi.org/10.1007/s11940-014-0308-3

Weitere Artikel der Ausgabe 8/2014

Current Treatment Options in Neurology 8/2014 Zur Ausgabe

Sleep Disorders (S Chokroverty, Section Editor)

Advances in the Treatment of Obstructive Sleep Apnea

Neurologic Ophthalmology and Otology (RK Shin, Section Editor)

Repositioning Maneuvers for Benign Paroxysmal Positional Vertigo

Neurologic Ophthalmology and Otology (RK Shin, Section Editor)

Treatment Options for Thyroid Eye Disease

Sleep Disorders (S Chokroverty, Section Editor)

Sleep Dysfunction and its Management in Parkinson’s Disease

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.